英文論文
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
Araki K, Sangai T, Miyamoto S, Maeda H, Shi-Chuang Z, Nakamura M, Ishii G, Hasebe T, Kusaka H, Akiyama T, Tokuda Y, Nagai K, Minami H, Ochiai A.
Inhibition of bone-derived insulin-like growth factor of human multiple myeloma in the human adult bone explanted in NOD/SCID mouse.
Int J Cancer 2005;118:2602-8
Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, Asaka M, Ochiai A.
Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like
Biochem Biophys Res Commun 2005;333:1011-16
Muto M, Miyamoto S, Hosokawa A, Doi T, Ohtsu A, Yoshida S, Endo Y, Hosokawa K, Saito D, Shim CS, Gossner L.
Endoscopic mucosal resection in the stomach using the insulated-tip needle-knife.
Endoscopy 2005;37:178-82
Miyamoto S, Nakamura M, Shitara K, Nakamura K, Ohki Y, Ishii G, Goya M, Kodama K, Sangai T, Maeda H, Shi-Chuang Z, Chiba T, Ochiai A.
Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers.
Clin Cancer Res 2005;11:3494-502
Sangai T, Ishii G, Kodama K, Miyamoto S, Aoyagi Y, Ito T, Magae J, Sasaki H, Nagashima T, Miyazaki M, Ochiai A.
Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma.
Int J Cancer 2005;115:885-92.
Kodama K, Ishii G, Miyamoto S, Goya M, Zhang SC, Sangai T, Yoshikawa T, Hasebe T, Hitomi Y, Izumi K, Ochiai A.
Laminin 5 expression protects against anoikis at aerogenous spread and lepidic growth of human lung adenocarcinoma.
Int J Cancer 2005;116:876-84.
Nakamura M, Miyamoto S, Maeda H, Zhang S, Sangai T, Ishii G, Hasebe T, Endoh Y, Saitoh N, Asaka M, Ochiai A.
Low levels of insulin-like growth factor type 1 receptor expression can predict the hepatic metastasis in Dukes’ C human colorectal cancers.
Clin Cancer Res 2004;10:8434-41
Goya M, Miyamoto S, Ohki Y, Nakamura K, Shitara K, Maeda H, Sangai T, Kodama K, Endoh Y, Ishii G, Hasebe T, Nagai K, Yonou H, Hatano T, Ogawa Y, Ochiai A.
Growth inhibition of human prostate cancer cells in human adult bone implanted into non-obese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.
Cancer Res 2004;64:6252-8
Miyamoto S, Endoh Y, Hasebe T, Ishii G, Kodama K, Goya M, Ono M, Saitoh N, Chiba T, Ochiai A.
Nuclear ?-catenin accumulation as a prognostic factor in Dukes’ D human colorectal cancers.
Oncol Rep 2004;12:245-51
Miyamoto S, Yano K, Sugimoto S, Ishii G, Hasebe T, Endoh Y, Kodama K, Goya M, Chiba T, Ochiai A.
Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3.
Cancer Res 2004;64:665-71